Shared Decision-making and Antimicrobial Stewardship in Secondary Care

NCT ID: NCT06605820

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-03

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To identify opportunities for antibiotic prescribing shared decision making between patients and prescribers in secondary care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a qualitative study with patients and clinicians in secondary care.

We will use semi-structured interviews with patients and clinicians to address the research question. Patients that have received antibiotics during a recent inpatient stay will be identified using the hospital electronic prescribing system and a letter inviting study participation will be included in their discharge medication pack. Senior prescribing decision makers will be recruited from participating hospitals. In total, we hope to carry out up to 50 interviews with patients and clinicians.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Antibiotic Prescribing is the Study Focus (no Condition)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

None - Interview Only

Intervention Type OTHER

None - Interview Only

Healthcare workers

None - Interview Only

Intervention Type OTHER

None - Interview Only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

None - Interview Only

None - Interview Only

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For clinicians:

* Participant is willing and able to give informed consent for participation in the study.
* Senior registrar or consultant medical or surgical doctor working at participating hospitals and caring for inpatients.
* Fluent in English.

For patients:

* Participant is willing and able to give informed consent for participation in the study.
* Male or Female, aged 16 years or above (no upper age limit).
* Good standard of speaking English and able to read and understand study materials.
* Received antibiotic for treatment of suspected or confirmed bacterial infection during inpatient stay.

Exclusion Criteria

* For clinicians:

* Prescribers not currently caring for inpatients

For patients:

• Patient who received prophylaxis antibiotics only
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oxford

OTHER

Sponsor Role collaborator

Royal Cornwall Hospitals Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Cornwall Hospital

Truro, Cornwall, United Kingdom

Site Status RECRUITING

Chelsea and Westminster Hospital

Truro, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Verity Teague

Role: CONTACT

44 01872256429

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Verity Teague

Role: primary

01872256429

Verity Teague

Role: primary

01872256429

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023.RCHT.05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Antibiotics on Urinary Microbiome
NCT04230746 WITHDRAWN EARLY_PHASE1